{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:50:58Z","timestamp":1791967858556,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154614","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:25Z","timestamp":1789799905000},"page":"154614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["N-(3\u2019-(Dimethylamino)propyl)amides based on 18\u03b2H-glycyrrhetinic acid retain P-glycoprotein inhibitory and MDR-reversing activities"],"prefix":"10.1016","volume":"837","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0410-5403","authenticated-orcid":false,"given":"Arseny D.","family":"Moralev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika V.","family":"Konoreva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana V.","family":"Salomatina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariman F.","family":"Salakhutdinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Zenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-9555","authenticated-orcid":false,"given":"Andrey V.","family":"Markov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154614_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114643","article-title":"Overcoming cancer Multi-drug resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges","volume":"162","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.154614_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103537","article-title":"ATP-binding cassette efflux transporters and MDR in cancer","volume":"28","author":"Pote","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2026.154614_bib3","series-title":"Resist. to Target. ABC Transp. Cancer","first-page":"1","article-title":"Role of P-Glycoprotein for resistance of tumors to anticancer drugs: from bench to bedside","author":"Volm","year":"2015"},{"key":"10.1016\/j.bbrc.2026.154614_bib4","doi-asserted-by":"crossref","DOI":"10.2174\/092986712800167392","article-title":"Three decades of P-gp inhibitors: skimming through several generations and scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154614_bib5","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s12672-025-03593-x","article-title":"Re-sensitization of cancer multidrug resistance through P-gp, MRP1 and BCRP modulation: advances in terpenoids based cancer therapy","volume":"16","author":"Pandey","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbrc.2026.154614_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109645","article-title":"Triterpenoids with modified A-ring as modulators of P-gp-dependent drug-resistance in cancer cells","volume":"348","author":"Rybalkina","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2026.154614_bib7","doi-asserted-by":"crossref","first-page":"48813","DOI":"10.1021\/acsomega.3c06202","article-title":"A novel 3-meta-Pyridine-1,2,4-oxadiazole derivative of glycyrrhetinic acid as a safe and promising candidate for overcoming P-Glycoprotein-Mediated multidrug resistance in tumor cells","volume":"8","author":"Moralev","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2026.154614_bib8","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.3390\/molecules29204939","article-title":"Soloxolone N-3-(Dimethylamino)propylamide Restores drug sensitivity of tumor cells with multidrug-resistant phenotype via inhibition of P-Glycoprotein efflux function","volume":"29","author":"Moralev","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.154614_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411912","article-title":"Soloxolone N-3-(Dimethylamino)propylamide suppresses tumor growth and mitigates doxorubicin-induced hepatotoxicity in RLS40 Lymphosarcoma-bearing mice","volume":"26","author":"Moralev","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154614_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ph15050603","article-title":"Novel soloxolone amides as potent anti-glioblastoma candidates: design, synthesis, in silico analysis and biological activities in vitro and in vivo","volume":"15","author":"Markov","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2026.154614_bib11","series-title":"Licorice: Biodiversity, Chemistry, and Use in Medicine [In Russian], Akademicheskoe Izd, Geo, Novosib","author":"Tolstikov","year":"2007"},{"key":"10.1016\/j.bbrc.2026.154614_bib12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/cbic.201000618","article-title":"Synthesis and pro-apoptotic activity of novel glycyrrhetinic acid derivatives","volume":"12","author":"Logashenko","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.bbrc.2026.154614_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154614_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12935-022-02624-9","article-title":"Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine","volume":"22","author":"Dhyani","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2026.154614_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1196\/annals.1378.090","article-title":"Animal model of drug-resistant tumor progression","volume":"1091","author":"Mironova","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2026.154614_bib16","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.3390\/ijms26094179","article-title":"Mapping the role of P-gp in multidrug resistance: insights from recent structural studies","volume":"26","author":"Tia","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154614_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098896","article-title":"Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO","volume":"9","author":"Cleasby","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154614_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/antiox10030349","article-title":"Nrf2 signaling pathway in chemoprotection and Doxorubicin resistance: potential application in drug discovery","volume":"10","author":"Mirzaei","year":"2021","journal-title":"Antioxidants"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601380X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601380X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:20:14Z","timestamp":1791966014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2601380X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":18,"alternative-id":["S0006291X2601380X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154614","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-(3\u2019-(Dimethylamino)propyl)amides based on 18\u03b2H-glycyrrhetinic acid retain P-glycoprotein inhibitory and MDR-reversing activities","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154614"}}